Impaired prostate tumorigenesis in Egr1-deficient mice

Citation
Sa. Abdulkadir et al., Impaired prostate tumorigenesis in Egr1-deficient mice, NAT MED, 7(1), 2001, pp. 101-107
Citations number
36
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
NATURE MEDICINE
ISSN journal
10788956 → ACNP
Volume
7
Issue
1
Year of publication
2001
Pages
101 - 107
Database
ISI
SICI code
1078-8956(200101)7:1<101:IPTIEM>2.0.ZU;2-#
Abstract
The transcription factor, early growth response protein 1 (ECR1), is overex pressed in a majority of human prostate cancers and is implicated in the re gulation of several genes important for prostate tumor progression. Here we have assessed the effect of Egr1 deficiency on tumor development in two tr ansgenic mouse models of prostate cancer (CR2-T-Ag and TRAMP). Using a comb ination of high-resolution magnetic resonance imaging and histopathological and survival analyses, we show that tumor progression was significantly im paired in Egr1(-/-) mice. Tumor initiation and tumor growth rate were not a ffected by the lack of Egr1; however, Egr1 deficiency significantly delayed the progression from prostatic intra-epithelial neoplasia to invasive carc inoma. These results indicate a unique role for Egr1 in regulating the tran sition from localized, carcinoma in situ to invasive carcinoma.